We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Sample and Liquid Handling Platforms Suited for All Lab Sizes

By LabMedica International staff writers
Posted on 08 Jul 2014
Print article
Tecan Fluent laboratory automation solution
Automated Sample and Liquid Handling Platform (Photo courtesy of TECAN GROUP LTD.)
Biotech and other life scientists who work with cell-based assays now have available a new line of advanced automated sample and liquid handling platforms.

Tecan (Männedorf, Switzerland) has introduced the Fluent laboratory automation solution, the latest addition to its laboratory automation portfolio.

The Fluent system is available in three sizes—offering deck capacities from 30 to 72 microplates—to suit the throughput requirements of almost any laboratory. The instrument boasts a built-in touchscreen interface that guides users through every task, making even the most sophisticated cell-based assays easy to run. Fluent’s three, task-specific robotic arms work in parallel for faster processing, and offer automated lid handling to maintain sterility and minimize evaporation.

The Fluent platform was designed for integration with a variety of cell biology devices. This allows the user to control every step of the workflow, including storage, transfer, manipulation, and measurement of cellular samples on a single instrument.

The Tecan HydroSpeed plate washer features extra-gentle wash settings that can be adjusted to suit specific cells, microplates, and applications, ensuring reproducible results even with weakly adherent cells.

“Today’s research landscape looks different from yesterday’s, with customers wanting systems that are faster, more versatile, and more cost efficient,” said Dr. Stefan Traeger, head of life sciences business at Tecan. “The Fluent laboratory automation solution has initially been developed to address the needs of cell biology laboratories as they move towards greater miniaturization and higher throughput assays, and our test sites and assay partners have been impressed by its speed and capabilities for automating even complex cell-based assays.”

Related Links:

Tecan


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more